[HTML][HTML] 硼替佐米联合沙利度胺和地塞米松治疗自体造血干细胞移植多发性骨髓瘤的Meta 分析
王海雪, 叶云 - 医药导报, 2016 - yydbzz.com
… bortezomib combined with dexamethasone and thalidomide in the treatment of autologous
stem cell transplantation (ASCT) in multiple myeloma (… The meta analysis results showed that …
stem cell transplantation (ASCT) in multiple myeloma (… The meta analysis results showed that …
自体造血干细胞移植治疗多发性骨髓瘤的新进展
何蓉会, 刘林 - 中国组织工程研究, 2013 - cjter.com
… multiple myeloma: A systematic review and meta-analysis of randomized controlled trials. …
Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell …
Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell …
[HTML][HTML] 我如何治疗年轻的多发性骨髓瘤患者
李娟 - Chinese Journal of Hematology, 2017 - ncbi.nlm.nih.gov
… 多发性骨髓瘤(multiple myeloma,MM)治疗的历程可分成三个阶段:传统化疗、造血干细胞移植
、新药或新药序贯移植时代。传统化疗的完全缓解(CR)率小于10%,中位总体生存(OS)期仅为…
、新药或新药序贯移植时代。传统化疗的完全缓解(CR)率小于10%,中位总体生存(OS)期仅为…
[HTML][HTML] 自体造血干细胞移植可改善多发性骨髓瘤患者的临床状态
宁雪琴, 魏小磊, 郭绪涛, 韦祁, 黄芬… - Journal of Southern …, 2021 - ncbi.nlm.nih.gov
… To evaluate the effect of autologous stem cell transplantation (ASCT) on treatment response
and survival outcomes in patients with newly diagnosed multiple myeloma (MM) receiving …
and survival outcomes in patients with newly diagnosed multiple myeloma (MM) receiving …
[HTML][HTML] 93 例70 岁以上多发性骨髓瘤患者的临床特点及转归
陈海敏, 周帆, 韦苇, 彭嵘, 石昊天… - Chinese Journal of …, 2017 - ncbi.nlm.nih.gov
… 多发性骨髓瘤(multiple myeloma,MM)是一种克隆性浆细胞异常增殖的恶性疾病,是血液系统
中较为常见的恶性肿瘤,多发于老年人,目前仍无法治愈[1]。十几年来,新药如蛋白酶体抑制剂、…
中较为常见的恶性肿瘤,多发于老年人,目前仍无法治愈[1]。十几年来,新药如蛋白酶体抑制剂、…
复发难治性多发性骨髓瘤治疗的现状与挑战
万一柯, 侯健 - 肿瘤防治研究, 2019 - zlfzyj.com
… treatment studies for relapsed/refractory multiple myeloma … outcomes in patients with multiple
myeloma: a meta-analysis[J]. … plus bortezomib and dexamethasone versus bortezomib and …
myeloma: a meta-analysis[J]. … plus bortezomib and dexamethasone versus bortezomib and …
伊沙佐米联合地塞米松治疗难治复发轻链型淀粉样变性的临床观察
徐维玮, 郭锦洲, 任贵生 - 肾脏病与透析肾移植杂志, 2021 - njcndt.com
… was 50%(1/2) in patients without bortezomib treatment previously, while 11 11%(1/9) in …
in patients with previously untreated multiple myeloma: an open⁃label phase 1/2 study. Lancet …
in patients with previously untreated multiple myeloma: an open⁃label phase 1/2 study. Lancet …
[PDF][PDF] 老年人多发性骨髓瘤的治疗
陈君敏 - 实用老年医学, 2014 - sylnyx.com
… prednisone compared with mel⁃ phalan and prednisone in previously untreated …
bortezomib/prednisone (VP):A ran⁃ domised trial in elderly untreated pa⁃ tients with multiple …
bortezomib/prednisone (VP):A ran⁃ domised trial in elderly untreated pa⁃ tients with multiple …
[HTML][HTML] 伴肾损害的初诊多发性骨髓瘤患者肾功能疗效影响因素
宋宇航, 张富婧, 胡蓉蓉, 陈苗, 杨辰… - Chinese Journal of …, 2023 - ncbi.nlm.nih.gov
… of renal function in newly diagnosed multiple myeloma(MM)patients with renal inadequacy.
… therapy in previously untreated multiple myeloma (MM) patients with various degrees of …
… therapy in previously untreated multiple myeloma (MM) patients with various degrees of …
甲磺酸萘莫司他可减轻神经缺血后的病理生理性损害
GZ Ghali, MGZ Ghali - 中国神经再生研究(英文版), 2020 - sjzsyj.com.cn
… duct of randomized prospective controlled trials in Western … to treat patients suffering from
multiple myeloma. Accordingly, … with the proteasome inhibitor bortezomib in treating this clonal …
multiple myeloma. Accordingly, … with the proteasome inhibitor bortezomib in treating this clonal …